PBYI

Puma Biotechnology Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth 6/10
  • Value 9/10
Puma Biotechnology sales and earnings growth
PBYI Growth
Good
  • Revenue Y/Y -0.91%
  • EPS Y/Y 0.00%
  • FCF Y/Y 7.38%
Puma Biotechnology gross and profit margin trends
PBYI Profitability
Good
  • Gross margin 74.50%
  • EPS margin 13.60%
  • ROIC 5Y 39.72%
Puma Biotechnology net debt vs free cash flow
PBYI Risk
Great
  • Debt / Equity 0.2
  • Debt / FCF 0.0
  • Interest coverage 6.4

Puma Biotechnology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗